Regeneron Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
02.08.24
/
50%
€990.00
Target price
02.08.25
€1,099.6
Performance (%)
-51.29%
End price
03.08.25
€482.20
Summary
This prediction ended on 03.08.25 with a price of €482.20. The BUY prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc. performed very badly with a performance of -51.29%. JPMorgan_Chase___Co_ has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €1.72 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 9.403% | 9.403% | 35.127% |
| iShares Core DAX® | 3,15 % | 1,50 % | 9,13 % |
| iShares Nasdaq 100 | 7,43 % | -1,58 % | 28,64 % |
| iShares Nikkei 225® | 8,57 % | -4,32 % | 53,03 % |
| iShares S&P 500 | 4,58 % | 1,92 % | 23,97 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at JPMorgan Chase & Co. from $1,150.00 to $1,200.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€639.20
02.02.26
02.02.26
€800.09
02.02.27
02.02.27
3.83%
18:27
18:27
Stopped prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€539.40
18.05.26
18.05.26
€731.51
18.05.27
18.05.27
22.87%
18:27
18:27
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€444.50
09.06.25
09.06.25
€700.56
09.06.26
09.06.26
19.15%
10.06.26
10.06.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€586.00
31.03.25
31.03.25
€922.40
31.03.26
31.03.26
13.34%
01.04.26
01.04.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€872.60
24.10.24
24.10.24
€1,064.9
24.10.25
24.10.25
-42.87%
25.10.25
25.10.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€974.20
17.06.24
17.06.24
€1,072.3
17.06.25
17.06.25
-54.45%
18.06.25
18.06.25